A carregar...

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

BACKGROUND: Differences exist between treatment recommendations regarding the choice of metformin as first-line therapy for type 2 diabetes patients according to body mass index (BMI). This study compared the efficacy of metformin monotherapy among normal-weight, overweight, and obese patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ji, Linong, Li, Hongmei, Guo, Xiaohui, Li, Yan, Hu, Renming, Zhu, Zhengying
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3585309/
https://ncbi.nlm.nih.gov/pubmed/23468941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0057222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!